Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
25.00
+0.76 (3.14%)
Apr 28, 2025, 4:00 PM EDT - Market closed

KMTS Income Statement

Millions USD. Fiscal year is May - Apr.
Fiscal Year
TTM FY 2024 FY 2023 FY 2021 FY 2020
Period Ending
Jan '25 Apr '24 Apr '23 Apr '21 Apr '20
Revenue
52.6427.817.63--
Revenue Growth (YoY)
589.86%264.54%---
Cost of Revenue
34.6627.4518.28--
Gross Profit
17.970.36-10.65--
Selling, General & Admin
82.469.9454.0113.96.52
Research & Development
14.0915.4915.7618.8122.8
Operating Expenses
96.4985.4369.7732.7129.32
Operating Income
-78.52-85.06-80.42-32.71-29.32
Interest Expense
-7.91-6.23-5.63-1.17-
Other Non Operating Income (Expenses)
1.69-0.091.83-0.04-
EBT Excluding Unusual Items
-83.2-91.38-84.22-33.91-29.32
Other Unusual Items
-1.79-2.72---
Pretax Income
-84.98-94.1-84.22-33.91-29.32
Income Tax Expense
0.010.020.020.190.15
Net Income
-84.05-94.12-84.24-34.1-29.47
Preferred Dividends & Other Adjustments
11.026.722.5--
Net Income to Common
-95.07-100.84-86.74-34.1-29.47
Shares Outstanding (Basic)
00000
Shares Outstanding (Diluted)
00000
EPS (Basic)
-898.50-953.06-819.76-322.29-278.50
EPS (Diluted)
-898.50-953.06-819.76-322.29-278.50
Free Cash Flow
-88.61-84.75-85.1-30.23-30.53
Free Cash Flow Per Share
-837.41-800.97-804.32-285.72-288.49
Gross Margin
34.15%1.30%-139.59%--
Operating Margin
-149.17%-305.83%-1054.01%--
Profit Margin
-180.62%-362.56%-1136.79%--
Free Cash Flow Margin
-168.33%-304.70%-1115.37%--
EBITDA
-68.88-73.5-75.57-32.29-28.84
EBITDA Margin
-130.86%-264.27%---
D&A For EBITDA
9.6311.564.860.420.48
EBIT
-78.52-85.06-80.42-32.71-29.32
Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q